Shanghai OPM Biosciences (688293.SH) major shareholder China Life Gainreduces its holding by 1%.

15/11/2024

GMT Eight

Shanghai OPM Biosciences (688293.SH) announced that the shareholder China Life Chengda (Shanghai) Health Industry Equity Investment Center (Limited Partnership) (referred to as "China Life Chengda") reduced its holdings of the company's shares by a total of 1.1477 million shares, representing 1.00% of the total share capital of the company, through centralized auction trading from November 7, 2024 to November 15, 2024.

VOBILE GROUP (03738) total revenue in the third quarter increased by approximately 29% year-on-year.

General Motors Company (GM.US)'s self-driving department, Cruise, admits to submitting a false report and is fined $500,000.

Contact: contact@gmteight.com

Shanghai OPM Biosciences (688293.SH) major shareholder China Life Gainreduces its holding by 1%.

RECOMMEND

JUNSHI BIO (01877): Tislelizumab approved for marketing by the UK Medicines and Healthcare products Regulatory Agency

US Stock Market Move | Vanguard Group increases holdings in GameStop Corp. Class A (GME.US), pre-market trading up nearly 3%

CHINA HK POWER (00931) issued a profit warning, expecting a mid-term loss attributable to shareholders of approximately HK$50 million to HK$65 million.